HotSpot Therapeutics Announces FDA Clearance of IND Applicat

HotSpot Therapeutics Announces FDA Clearance of IND Application for HST-1011, An Investigational Small Molecule Allosteric Inhibitor of CBL-B

/PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies for...

Related Keywords

Boston , Massachusetts , United States , Tim Reilly , Drug Administration , Prnewswire Hotspot Therapeutics Inc , Hotspot Therapeutics Inc , Spot Therapeutics , Investigational New Drug , Smart Allostery , Chief Development Officer , Hotspot Therapeutics ,